These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3332433)

  • 41. Use of antiplatelet agents for prevention of ischemic stroke.
    Callison RC; Adams HP
    Neurol Clin; 2008 Nov; 26(4):1047-77, ix. PubMed ID: 19026902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial.
    Serebruany VL; Malinin AI; Sane DC; Jilma B; Takserman A; Atar D; Hennekens CH
    Eur J Pharmacol; 2004 Sep; 499(3):315-24. PubMed ID: 15381054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Therapeutic approach to TIA and acute cerebral stroke in geriatric patients using a platelet aggregation inhibiting and vasoactive drug].
    Cucinotta D; Monica C; Silvestrini C; Ceccato S; Cocchi C
    G Clin Med; 1979 Apr; 60(4):301-9. PubMed ID: 488589
    [No Abstract]   [Full Text] [Related]  

  • 44. Protective mechanisms of inosine in platelet activation and cerebral ischemic damage.
    Hsiao G; Lin KH; Chang Y; Chen TL; Tzu NH; Chou DS; Sheu JR
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1998-2004. PubMed ID: 15976325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Rheologic properties of the blood in stroke patients].
    Fedin AI; Teterina EB; Stepashkin VE; Iafaeva EI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(11):1627-35. PubMed ID: 726756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Premorbid antiplatelet use and ischemic stroke outcomes.
    Li HF; Pan XD
    Neurology; 2006 Nov; 67(9):1723; author reply 1723. PubMed ID: 17101925
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effects of GABA and piracetam on the development of experimental cerebral infarction in rats and platelet aggregation in patients with cerebrovascular disorders].
    Amroian EA; Vartazarian ND; Parsamian LK; Balian LS
    Biull Eksp Biol Med; 1990 Aug; 110(8):124-7. PubMed ID: 2127234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Optimal dose of aspirin in ischemic cerebrovascular disorders].
    Suzuki K; Mizuno Y; Niijima S; Yoshida M; Adachi S; Haga T
    Nihon Naika Gakkai Zasshi; 1983 Nov; 72(11):1547-52. PubMed ID: 6676414
    [No Abstract]   [Full Text] [Related]  

  • 49. FK419, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, ameliorates brain infarction associated with thrombotic focal cerebral ischemia in monkeys: comparison with tissue plasminogen activator.
    Maeda M; Moriguchi A; Mihara K; Aoki T; Takamatsu H; Matsuoka N; Mutoh S; Goto T
    J Cereb Blood Flow Metab; 2005 Jan; 25(1):108-18. PubMed ID: 15678117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of low dose acetylsalicylic acid upon plasma thromboxane B2 levels and platelet aggregation in ischemic stroke patients.
    Lee TK; Chen YC; Kuo TL; Lien IN; Liu MC; Huang ZS
    Clin Chim Acta; 1989 Oct; 184(3):323-8. PubMed ID: 2612002
    [No Abstract]   [Full Text] [Related]  

  • 51. Antithrombotic therapy for ischemic cerebrovascular disease.
    Biller J; Love BB; Gordon DL
    Semin Neurol; 1991 Dec; 11(4):353-67. PubMed ID: 1811292
    [No Abstract]   [Full Text] [Related]  

  • 52. [Specific measures in drug therapy in stroke. Anticoagulants, inhibitors of thrombocyte aggregation, initial barbiturate therapy].
    Soyka D
    Nervenarzt; 1980 Aug; 51(8):443-8. PubMed ID: 7003417
    [No Abstract]   [Full Text] [Related]  

  • 53. Treating acute ischaemic stroke.
    Bath PM
    BMJ; 1995 Jul; 311(6998):139-40. PubMed ID: 7613412
    [No Abstract]   [Full Text] [Related]  

  • 54. Ischemic stroke treated with Ligusticum chuanxiong.
    Chen KJ; Chen K
    Chin Med J (Engl); 1992 Oct; 105(10):870-3. PubMed ID: 1291208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating platelet aggregates in cerebrovascular diseases. Preliminary data.
    Carrieri P; La Pia S; Indaco A; Pisano P; Orefice G; Iadevaia V
    Acta Neurol (Napoli); 1981 Jun; 3(3):500-4. PubMed ID: 7282470
    [No Abstract]   [Full Text] [Related]  

  • 56. [Thrombocyte-vascular and sero-coagulation hemostasis, and blood lipids in the acute period of ischemic stroke].
    Iasamanova AN; Martynov MIu; Sudmol NN
    Klin Med (Mosk); 2005; 83(11):26-9. PubMed ID: 16404935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Are anticoagulants better than antiplatelet agents for treatment of acute ischemic stroke?
    Griffin G
    Am Fam Physician; 2003 Oct; 68(7):1307-8. PubMed ID: 14567484
    [No Abstract]   [Full Text] [Related]  

  • 58. A multiparametric index of platelet in vitro aggregation in cerebrovascular disease.
    Gazzaniga PP; Ferroni P; Mina C; Pulcinelli FM; Rizzo PA
    Ital J Neurol Sci; 1987 Dec; 8(6):561-6. PubMed ID: 3429215
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Action of oren-gedoku-to on platelet aggregation in vitro.
    Mori M; Hojo E; Takano K
    Am J Chin Med; 1991; 19(2):131-43. PubMed ID: 1816725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cilostazol in patients with ischemic stroke.
    Al-Qudah ZA; Hassan AE; Qureshi AI
    Expert Opin Pharmacother; 2011 Jun; 12(8):1305–1315. PubMed ID: 21548722
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.